Marie Westwood

TL;DR: The QUADAS-2 tool will allow for more transparent rating of bias and applicability of primary diagnostic accuracy studies.

TL;DR: There was moderate- quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity and low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome.

TL;DR: This work presents PROBAST (Prediction model Risk Of Bias ASsessment Tool), a tool to assess the ROB and concerns regarding the applicability of diagnostic and prognostic prediction model studies, and develops the accompanying explanation and elaboration document.

TL;DR: The rationale behind the domains and signaling questions, how to use them, and how to reach domain-level and overall judgments about ROB and applicability of primary studies to a review question are described.

TL;DR: The evidence suggests that urine cytology has no application in ruling out malignancy or excluding patients from further investigation and the economic model for the detection of microhaematuria found that immediate microscopy following a positive dipstick test would improve diagnostic efficiency as it eliminates the high number of false positives produced by dipstick testing.